Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Invite your friends, family, colleagues or clients to an exceptional black-tie event in the heart of London. Every ticket, every bid, every moment helps us move closer to a cure.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Join the type 1 diabetes community and come together, raising awareness and vital funds for T1D.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > News & events > News > Type 1 Diabetes Grand Challenge invests £5 million to kick off the race towards a cure
Dr Victoria Salem at Imperial College London
We’re excited to reveal the first research projects funded by the Type 1 Diabetes Grand Challenge, our partnership with the Steve Morgan Foundation and Diabetes UK.
£5 million will support a trio of exceptional scientists to develop new and improved treatments for type 1 diabetes and marks the start of a £50 million programme of research, made possible by the Steve Morgan Foundation’s landmark investment.
The funding goes to scientists in different corners of the UK, who will each solve different problems to help propel us towards a cure.
Dr James Cantley, at the University of Dundee, will develop new drugs to help people with type 1 diabetes grow back their own beta cells inside their pancreas. This approach could avoid problems with the immune system rejecting transplanted ‘foreign’ donor or lab-made beta cells and allow the pancreas to produce its own insulin again.
Dr Cantley said, “Regenerating beta cells in the pancreas has the potential to revolutionise the treatment of type 1 diabetes, by replacing cells destroyed by the immune attack, and ultimately leading to stable blood sugar levels and a life free from insulin injections.”
Dr Victoria Salem, at Imperial College London, will use state-of-the-art 3D bioprinting to ‘print’ a device that can be implanted into people with type 1 diabetes to deliver a new supply of beta cells.
The device will act as a barrier and protect the beta cells sitting inside, by blocking attacking immune cells, while still letting in vital nutrients they need to survive.
Dr Salem said, “The dream for a cell cased cure for type 1 diabetes is now tantalisingly close – I’m so excited and honoured to be a part of this journey.”
Professor Sarah Richardson, at the University of Exeter, will probe how and why a person’s immune system destroys their own beta cells and how this process may differ between people with type 1 diabetes. She’ll also study how beta cells can fight back against the immune attack.
With this knowledge, scientists could develop an armoury of new treatments that target different lines of the immune system’s attack.
Professor Richardson said, “Ultimately, this will help us tailor existing and emerging therapies to the individual, maximising the benefits for people with type 1 diabetes.”
Read more about the Grand Challenge researchers’ plans on the Type 1 Diabetes Grand Challenge website.
Breakthrough T1D has helped organise an event hosted by Member of European Parliament Tomislav Sokol titled ‘Accelerating Breakthroughs to Address Unmet Needs in Type 1 Diabetes.’
This study is the largest and most comprehensive to date examining human pancreas tissue for signs of viral infection in people with and without type 1 diabetes (T1D).
This charitable pledge by the Bukhman Foundation represents the UK’s largest philanthropic commitment towards funding research to accelerate new treatments and a cure for type 1 diabetes.
We have launched a new 10-year strategy aimed at driving significant advancements in type 1 diabetes (T1D) research, treatment, and care.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.
